semaglutide and osa Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Obstructive Sleep Apnea Syndrome Management: A Narrative Review Obstructive Sleep Apnea and Cardiometabolic...

Granhall C, Sndergaard FL, Thomsen M, Anderson TW

Understanding these differences is key to choosing the right option for your lifestyle

In fact, it improves the quality of weight loss by shifting the ratio toward more fat loss and less muscle loss

Although investor concerns about the MedTech Sector have been based on expected declines in obesity rates with the surging adoption of GLP-1s, IQVIA MedTechs analysis of the data tells a different story, overall, that - to date - obesity diagnoses remain stable during the rise of GLP-1 uptake as depicted below: As a result, the resilience of obesity diagnosis occurring despite the rising uptake of GLP-1s should serve as a positive general signal for MedTech industry players to counter investor concerns about the potential of reduced demand, or that the demand may be net-neutral, rather than a sudden decline

The most consistent safety pattern in published trial reports is gastrointestinal

We use peptides for weight loss as part of our GLP-1 weight loss program to help regulate blood sugar and reduce cravings